Santa Clara, CA, April 11, 2023 (Globe Newswire) -- Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (“IVL”) to treat severely calcified cardiovascular disease, today announced the completion of its previously announced acquisition of Neovasc Inc. (“Neovasc”).
Read full article here.
San Diego, CA, April 3, 2024 (Reuters) -- Alterome Therapeutics announced that it has successfully secured $132 million. Spearheaded by Goldman Sachs Alternatives, this a series B financing brings f
Henderson, NV, April 8, 2024 (Zura Bio) -- Zura Bio, a company focused on advancing treatments for autoimmune and inflammatory conditions, has named Robert Lisicki as its new Chief Executive Officer
Cambridge, MA, April 3, 2024 (Business Wire) -- Obsidian Therapeutics, Inc., a cutting-edge clinical-stage biotechnology company specializing in engineered cell and gene therapies, recently conclude
